Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis

Journal of Virology

Volumn 81, Issue 9, 2007, Pages 4848-4857

  Shkreli, Marina ^a,b,c   Dambrine, Ginette ^a   Soubieux, Denis ^a   Kut, Emmanuel ^a   Rasschaert, Denis ^a,b  

^a UR1282   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; NUCLEOTIDE; PROTEIN SUBUNIT; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ANIMAL CELL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CARCINOGENESIS; CHICKEN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E BOX ELEMENT; ENZYME ACTIVITY; GENE CONTROL; LYMPHOBLASTOID CELL; LYMPHOMAGENESIS; MITOSIS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; T CELL LYMPHOMA; TELOMERE; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS GENOME; VIRUS STRAIN;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHICKENS; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, GALLID; LUCIFERASES; LYMPHOMA, T-CELL; MUTAGENESIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE;

AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 34247639366     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02530-06     Document Type: Article

References (37)

1. Blasco, M. A., and W. C. Hahn. 2003. Evolving views of telomerase and cancer. Trends Cell Biol. 13:289-294.
2. Brown, A. C., S. J. Baigent, L. P. Smith, J. P. Chattoo, L. J. Petherbridge, P. Hawes, M. J. Allday, and V. Nair. 2006. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. USA 103:1687-1692.
3. Calnek, B. W. 1986. Marek's disease-a model for herpesvirus oncology. Crit. Rev. Microbiol. 12:293-320.
4. Cayuela, M. L., J. M. Flores, and M. A. Blasco. 2005. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep. 6:268-274.
5. Cebrian, J., C. Kaschka-Dierich, N. Berthelot, and P. Sheldrick. 1982. Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey. Proc. Natl. Acad. Sci. USA 79:555-558.
6. Chang, L. Y., S. C. Lin, C. S. Chang, Y. K. Wong, Y. C. Hu, and K. W. Chang. 1999. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J. Oral Pathol. Med. 28:389-396.
7. Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
8. Djeraba, A., N. Bernardet, G. Dambrine, and P. Quere. 2000. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-γ-mediated viral inhibition. Virology 277:58-65.
9. Djeraba-AitLounis, A., D. Soubieux, W. Klapper, and D. Rasschaert. 2004. Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1. Vet. Pathol. 41:405-407.
10. Fragnet, L., M. A. Blasco, W. Klapper, and D. Rasschaert. 2003. The RNA subunit of telomerase is encoded by Marek's disease virus. J. Virol. 77:5985-5996.
11. Fragnet, L., E. Kut, and D. Rasschaert. 2005. Comparative functional study of the viral telomerase RNA based on natural mutations. J. Biol. Chem. 280:23502-23515.
12. Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653-699.
13. Greenberg, R. A., R. C. O'Hagan, H. Deng, Q. Xiao, S. R. Hann, R. R. Adams, S. Lichtsteiner, L. Chin, G. B. Morin, and R. A. DePinho. 1999. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18:1219-1226.
14. Guilleret, I., P. Yan, L. Guillou, R. Braunschweig, J. M. Coindre, and J. Benhattar. 2002. The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation. Carcinogenesis. 23:2025-2030.
15. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
16. Horikawa, I., P. L. Cable, S. J. Mazur, E. Appella, C. A. Afshari, and J. C. Barrett. 2002. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol. Biol. Cell 13: 2585-2597.
17. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
18. Kyo, S., T. Kanaya, M. Takakura, M. Tanaka, and M. Inoue. 1999. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J. Cancer 80:60-63.
19. Kyo, S., M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue. 2000. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28:669-677.
20. Levy, A. M., Y. Izumiya, P. Brunovskis, L. Xia, M. S. Parcelle, S. M. Reddy, L. Lee, H.-W. Chen, and H.-J. Kung. 2003. Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J. Virol. 77:12841-12851.
21. Lupiani, B., L. F. Lee, X. Cui, I. Gimeno, A. Anderson, R. W. Morgan, R. F. Silva, R. L. Witter, H. J. Kung, and S. M. Reddy. 2004. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. USA 101:11815- 11820.
22. Maitra, A., K. Yashima, A. Rathi, C. F. Timmons, B. B. Rogers, J. W. Shay, and A. F. Gazdar. 1999. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85:741-749.
23. Matsudo, H., A. Otsuka, Y. Ozawa, and M. Ono. 2003. Disruption of the PU.1 gene in chicken B lymphoma DT40 cells and its effect on reported target gene expression. Gene 322:169-174.
24. Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
25. Nair, S. K., and S. K. Burley. 2003. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112:193-205.
26. Rathi, A., K. Hur, A. F. Gazdar, J. S. Bae, J. J. Jang, and D. Y. Kim. 1999. Telomerase RNA expression during progression of gastric cancer. Hum. Pathol. 30:1302-1308.
27. Schat, K. A., C-L. Chen, B. W. Calnek, and D. Char. 1991. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J. Virol. 65:1408-1413.
28. Seth, A., and D. K. Watson. 2005. ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41:2462-2478.
29. Takakura, M., S. Kyo, T. Kanaya, H. Hirano, J. Takeda, M. Yutsudo, and M. Inoue. 1999. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:551-557.
30. Trapp, S., M. S. Parcells, J. P. Kamil, D. Schumacher, B. K. Tischer, P. M. Kumar, V. K. Nair, and N. Osterrieder. 2006. A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J. Exp. Med. 203:1307-1317.
31. Veldman, T., X. Liu, H. Yuan, and R. Schlegel. 2003. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. USA 100:8211-8216.
32. Wang, J., L. Y. Xie, S. Allan, D. Beach, and G. J. Hannon. 1998. Myc activates telomerase. Genes Dev. 12:1769-1774.
33. Wu, K. J., C. Grandori, M. Amacker, N. Simon-Vermot, A. Polack, J. Lingner, and R. Dalla-Favera. 1999. Direct activation of TERT transcription by c-MYC. Nat Genet. 21:220-224.
34. Xin, J. H., A. Cowie, P. Lachance, and J. A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:481-496.
35. Yi, X., V. M. Tesmer, I. Savre-Train, J. W. Shay, and W. E. Wright. 1999. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol. Cell. Biol. 19:3989-3997.
36. Zhao, J., A. Bilsland, S. F. Hoare, and W. N. Keith. 2003. Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Lett. 536:111-119.
37. Zhao, J. Q., R. M. Glasspool, S. F. Hoare, A. Bilsland, I. Szatmari, and W. N. Keith. 2000. Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia 2:531-539.